AzTrials
AzTrials

PPROMMOCANCT05773014

Digital vs. Speculum Exams for PPROM

A study testing Speculum Exams and Digital Exams in people with PPROM, run by Washington University School of Medicine at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

After preterm prelabor rupture of membranes (PPROM)[breaking of the amniotic sac prior to 37 weeks gestation in pregnancy], patients are recommended for inpatient admission and close monitoring for complications including preterm labor, intraamniotic infection (infection of the sac around the baby), and placental… Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
PPROM
What is being tested?
Speculum Exams and Digital Exams
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
86 participants
Where
1 siteUnited States
Study dates
27 Mar 2023to 1 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • 22 weeks 0 days gestation to 33 weeks 5 days gestation
  • Clinical or laboratory confirmation of PPROM
  • At least 8 hours after rupture event
  • English speaking
  • Notably, for patients <25 weeks, approach for enrollment will be deferred until after the patient has discussed their desires for fetal resuscitation with the care team and are at a gestational age where they would desire this resuscitation.

Who cannot join

  • Contraindications to digital examination
  • COVID-19 positive on admission

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nandini Raghuraman, MD contact

3142732939

nraghuraman@wustl.edu

Jaime Strickland contact

3147471390

jaime.strickland@wustl.edu

United States1 site, 1 recruiting
  • Barnes Jewish Hospital

    St Louis, Missouri, 63108

    Nandini Raghuraman, MD, nraghuraman@wustl.edu

    Recruiting

Other trials in United States

About this study

Official title: Digital Versus Speculum Exams in Preterm Prelabor Rupture of Membranes: A Randomized Controlled Trial

After preterm prelabor rupture of membranes (PPROM)[breaking of the amniotic sac prior to 37 weeks gestation in pregnancy], patients are recommended for inpatient admission and close monitoring for complications including preterm labor, intraamniotic infection (infection of the sac around the baby), and placental abruption (separation of the placenta from wall of the uterus). When evaluation of cervical dilation is clinically indicated, obstetricians traditionally perform sterile speculum exams due to concern for decrease in pregnancy latency (length of time between breaking the water and delivery) with sterile digital exams in retrospective studies. These studies are concerning, however, by the indications for the exams and are at risk for confounding by indication. This is a randomized, non-inferiority trial to examine if sterile digital versus speculum exams effect latency of pregnancy in patients with PPROM.

Conditions
PPROM
Being tested
Speculum Exams, Digital Exams
Keywords
PPROM, speculum exam, preterm birth, preterm prelabor rupture of membranes
Medical subject headings
Preterm Premature Rupture of the Membranes, Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Speculum ExamsProcedure or surgery

    Same as arm

  • Digital ExamsProcedure or surgery

    Same as arm

Study groups in NCT05773014
Study groupRoleWhat they receive
Speculum ExamsActive comparatorIf a patient requires cervical evaluation after PPROM, their cervix will be evaluated with a sterile speculum exam. A sterile speculum with lubricating jelly will be inserted into the patient's vagina to visualize the cervix and visually estimate cervical dilation and effacement.
Receives: Procedure: Speculum Exams
Digital ExamsActive comparatorIf a patient requires cervical evaluation after PPROM, their cervix will be evaluated with a digital exam. The provider will wear sterile gloves with lubricating jelly and will palpate the cervix to assess cervical dilation, effacement, and station.
Receives: Procedure: Digital Exams

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pregnancy latency

    time from admission to delivery

    Measured: up to 10 weeks

Secondary outcomes (17)
  1. Maternal chorioamnionitis

    Per criteria of American College of Obstetricians and Gynecologists (ACOG): includes fever greater than or equal to 100.4 degrees Farenheit plus an additional sign such as fundal tenderness, white blood cell count >15, purulent vaginal discharge, fetal tachycardia, or placental culture with finding of chorioamnionitis. Suspected chorioamnionitis can also be diagnosed with isolated fever >102.2 degrees Fahrenheit

    Measured: Prior to delivery

  2. Endomyometritis

    Clinical diagnosis of uterine infection after delivery, typically with fever and fundal tenderness

    Measured: Within 2 weeks of delivery

  3. Maternal sepsis

    Defined as bacteremia with evidence of organ dysfunction

    Measured: Within 2 weeks of delivery

  4. Maternal wound infections

    As diagnosed by the clinicians

    Measured: Within 2 weeks of delivery

  5. Maternal intensive care unit (ICU) admission

    transfer to ICU or readmission to ICU

    Measured: Within 2 weeks of delivery

  6. Maternal death

    Death of mother

    Measured: Within 2 weeks postpartum

  7. Composite neonatal morbidity

    Need for respiratory support, neonatal sepsis, intraventricular hemorrhage, hypoxic ischemic encephalopathy, necrotizing enterocolitis, pneumonia, or neonatal demise

    Measured: 28 days of life

  8. Length of neonatal intensive care unit (NICU) admission

    From delivery until discharge from the NICU

    Measured: Up to 1 year

  9. Need for respiratory support

    One or more of the following: Continuous positive airway pressure (CPAP) or high-flow nasal cannula for at least 2 consecutive hours, supplemental oxygen with a fraction of inspired oxygen of at least 0.30 for at least 4 continuous hours, extracorporeal membrane oxygenation (ECMO), or mechanical ventilation

    Measured: 28 days of life

  10. Neonatal sepsis at <72 hours of life

    must be confirmed on blood culture

    Measured: Within 72 hours of birth

  11. Neonatal sepsis at >72 hours of life

    must be confirmed on blood culture

    Measured: 28 days of life

  12. Neonatal intraventricular hemorrhage (IVH)

    Seen on head ultrasound

    Measured: 28 days of life

  13. Necrotizing enterocolitis (NEC)

    As diagnosed by NICU team

    Measured: 28 days of life

  14. Hypoxic ischemic encephalopathy

    As diagnosed by NICU team

    Measured: 28 days of life

  15. Neonatal pneumonia

    As diagnosed by NICU team

    Measured: 28 days of life

  16. Neonatal death

    As documented in the EMR

    Measured: During NICU admission, up to 1 year

  17. Patient satisfaction with exams

    Survey regarding their experience with cervical exams

    Measured: At delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2023
  2. Study start27 Mar 2023
  3. Primary completion1 Mar 2027 (estimated)
  4. Study completion1 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
86 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05773014
Sponsor's protocol ID
202301012
Acronym
MOCA
Status last verified
Dec 2025
First submitted
21 Feb 2023
Last updated
5 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Sukcharoen N, Vasuratna A. Effects of digital cervical examinations on duration of latency period, maternal and neonatal outcome in preterm premature rupture of membranes. J Med Assoc Thai. 1993 Apr;76(4):203-9.

    PubMed 8113640
  • Alexander JM, Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Meis PJ, Moawad AH, Iams JD, Vandorsten JP, Paul RH, Dombrowski MP, Roberts JM, McNellis D. The impact of digital cervical examination on expectantly managed preterm rupture of membranes. Am J Obstet Gynecol. 2000 Oct;183(4):1003-7. doi: 10.1067/mob.2000.106765.

    PubMed 11035354
  • Lewis DF, Major CA, Towers CV, Asrat T, Harding JA, Garite TJ. Effects of digital vaginal examinations on latency period in preterm premature rupture of membranes. Obstet Gynecol. 1992 Oct;80(4):630-4.

    PubMed 1407885
  • Singhal, S., Puri, M., & Gami, N. (2011). An analysis of factors affecting the duration of latency period and its impact on neonatal outcome in patients with PPROM. International Journal of Infertility and Fetal Medicine. 2012; 3(3): 87-91.

Questions about this trial

What is this clinical trial studying?

A study testing Speculum Exams and Digital Exams in people with PPROM, run by Washington University School of Medicine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nandini Raghuraman, MD (3142732939, nraghuraman@wustl.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pregnancy latency (time frame: up to 10 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05773014, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in